1 unknown. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Hepatomegaly: new trials by email Literature Review of Hepatomegaly trials Research Report on Hepatomegaly
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open-Label Extension of LOCKCYST Trial lanreotide - Polycystic Liver Disease, Hepatomegaly | Phase 2 / Phase 3 | Unknown | Radboud University Medical Center | 54 | 2008-04-01 | 2008-11-13 |
Liver Diseases (1) · Multiple Pterygium Syndrome, Autosomal Dominant (1) · Polycystic Kidney Diseases (1) · Polycystic liver disease (1)
Abnormalities, Multiple (1) · Ciliopathies (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Digestive System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genetic Diseases, Inborn (1) · Hypertrophy (1) · Kidney Diseases (1) · Kidney Diseases, Cystic (1) · Male Urogenital Diseases (1) · Pathological Conditions, Anatomical (1) · Pathological Conditions, Signs and Symptoms (1) · Urogenital Diseases (1)
lanreotide (1)
Radboud University Medical Center (1)
Belgium (1) · Netherlands (1)
Frederik Nevens, MD, PhD (1) · Joost PH Drenth, PhD (1) · Loes van Keimpema, MSc (1)